Breakthroughs for Diabetes Treatments
Reading Time: 9 minutes. >>
Summary: Recently pharmaceutical firms have released new diabetes treatments, including one in the past week. Moreover, a promising new therapy that attacks the root cause of type 2 diabetes is in the development pipeline. [This article first appeared on the LongevityFacts.com website. Author: Brady Hartman. ]
The CDC recently shocked the public when they reported that 40% of Americans walking around today would develop type 2 diabetes.
Many people develop type 2 diabetes as they age because their body’s response to insulin – the hormone that controls sugar levels – gets weaker.
Fortunately, scientists have discovered new treatments for the disease and have more in the pipeline. One such drug, ertugliflozin (brand name Steglatro) was released less than a week ago.
Moreover, researchers at UCSD are developing a promising new therapy that attacks type 2 diabetes at its cellular roots.
Furthermore, doctors have developed a medication maintenance program, which can help prevent type 2 diabetics from health-robbing complications such as blindness, heart and kidney disease, and peripheral vascular disease.
There is also hope for type 1 diabetics, as scientists are working on improved insulin delivery devices, replacing damaged pancreases with stem cell-derived islet cells and the novel ‘pancreas in a box‘ that may restore normal insulin regulation.
Type 2 Diabetes Epidemic
Diabetes has been a documented human disorder for millennia, but only in recent decades has it developed into an epidemic. Mentions of the condition in ancient medical text Continue reading